Dr. Duncan S. Stearns
Claim this profileRainbow Babies and Childrens Hospital
Expert in Tumors
Expert in Brain Tumor
55 reported clinical trials
110 drugs studied
About Duncan S. Stearns
Education:
- Obtained MD from Case Western Reserve University School of Medicine in 2009.
- Completed Residency in Pediatrics at Rainbow Babies and Children's Hospital in 2012.
- Finished Fellowship in Pediatric Cardiology at Rainbow Babies and Children's Hospital in 2015.
Experience:
- Serving as an Attending Physician in Pediatric Cardiology at Rainbow Babies and Children's Hospital since 2015.
- Holds the position of Assistant Professor of Pediatrics at Case Western Reserve University School of Medicine.
Area of expertise
1Tumors
Global LeaderStage I
Stage IV
Stage II
2Brain Tumor
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Duncan S. Stearns is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Duncan S. Stearns
Clinical Trial Related7 years of experience running clinical trials · Led 55 trials as a Principal Investigator · 21 Active Clinical TrialsTreatments Duncan S. Stearns has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Doxorubicin Hydrochloride
- Nivolumab
- Vincristine Sulfate
Breakdown of trials Duncan S. Stearns has run
Tumors
Brain Tumor
Neuroblastoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Duncan S. Stearns specialize in?
Duncan S. Stearns focuses on Tumors and Brain Tumor. In particular, much of their work with Tumors has involved Stage I patients, or patients who are Stage IV.
Is Duncan S. Stearns currently recruiting for clinical trials?
Yes, Duncan S. Stearns is currently recruiting for 19 clinical trials in Cleveland Ohio. If you're interested in participating, you should apply.
Are there any treatments that Duncan S. Stearns has studied deeply?
Yes, Duncan S. Stearns has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Duncan S. Stearns?
Apply for one of the trials that Duncan S. Stearns is conducting.
What is the office address of Duncan S. Stearns?
The office of Duncan S. Stearns is located at: Rainbow Babies and Childrens Hospital, Cleveland, Ohio 44106 United States. This is the address for their practice at the Rainbow Babies and Childrens Hospital.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.